Medications for Uveal Melanoma
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Uveal Melanoma.
Found 2 Approved Drugs for Uveal Melanoma
Kimmtrak
Generic Name
Tebentafusp
Kimmtrak
Generic Name
Tebentafusp
Form: Injection
Method of administration: Intravenous
FDA approval date: January 26, 2022
Classification: Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager
KIMMTRAK is indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma. KIMMTRAK is a bispecific gp100 peptide-HLA-directed CD3 T cell engager indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma ( 1.
Melphalan
Brand Names
IVRA, Hepzato, Evomela
Melphalan
Brand Names
IVRA, Hepzato, Evomela
Form: Injection, Kit
Method of administration: Intra-arterial, Intravenous
FDA approval date: January 10, 2013
Classification: Alkylating Drug
Multiple Myeloma-Palliative Treatment IVRA is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. IVRA is an alkylating drug indicated for palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. ( 1 )
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances